The administration will reportedly advise women to avoid Tylenol unless they need it to fight a fever. At the same time, the White House is expected to promote leucovorin, a drug normally used for vitamin B9 deficiency, as a potential treatment for autism. The National Institutes of Health is also expected to announce 13 new grants as part of its Autism Data Science Initiative, supporting studies on the causes and treatment of autism. Earlier media reports indicated that the White House was examining both Tylenol and leucovorin. Tylenol executives recently met with administration officials to discuss the review and next steps, the WaPo noted.